Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands joint study group for ovarian cancer
Authors:
- 1 July 1987
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (7) , 997-998
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- The podophyllotoxin derivatives VP16-213 and VM26Cancer Chemotherapy and Pharmacology, 1982
- VM26 (NSC-122819): A clinical study in advanced cancer of the lung and ovary1978